DTB podcast
Summary: From June 2023, all our podcasts will move to https://dtbbmj.podbean.com. You can continue with your subscription on your favourite podcast App. For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship. Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page - https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
- Visit Website
- RSS
- Artist: BMJ Group
- Copyright: 643134
Podcasts:
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:A risky business? DTB 2010; 48: 25Using NSAIDs in cardiovascular disease DTB 2010; 48: 26 - 29Managing primary hyperparathyroidism in primary care DTB 2010; 48: 30 - 33Body surface area for adjustment of drug dose DTB 2010; 48: 33 - 36
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:A risky business? DTB 2010; 48: 25Using NSAIDs in cardiovascular disease DTB 2010; 48: 26 - 29Managing primary hyperparathyroidism in primary care DTB 2010; 48: 30 - 33Body surface area for adjustment of drug dose DTB 2010; 48: 33 - 36
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Patient safety first? DTB 2010; 48: 13Management of community-associated MRSA DTB 2010; 48: 14 - 19▼Pregabalin for generalised anxiety disorder DTB 2010; 48: 19 - 22A change of units for HbA1c DTB 2010; 48: 23 - 24Conversion chart for HbA1c values
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Patient safety first? DTB 2010; 48: 13Management of community-associated MRSA DTB 2010; 48: 14 - 19▼Pregabalin for generalised anxiety disorder DTB 2010; 48: 19 - 22A change of units for HbA1c DTB 2010; 48: 23 - 24Conversion chart for HbA1c values
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:More on high street mole checks DTB 2010; 48: 1Management of medication overuse headache DTB 2010; 48: 2 - 6Cognitive behavioural therapy for schizophrenia DTB 2010; 48: 6 - 9Tocilizumab for rheumatoid arthritis DTB 2010; 48: 9 - 12
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:More on high street mole checks DTB 2010; 48: 1Management of medication overuse headache DTB 2010; 48: 2 - 6Cognitive behavioural therapy for schizophrenia DTB 2010; 48: 6 - 9Tocilizumab for rheumatoid arthritis DTB 2010; 48: 9 - 12
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:C. difficile outside hospital DTB 2009; 47: 133Managing gastro-oesophageal reflux in infants DTB 2009; 47: 134 - 137Strong opioids for osteoarthritis in primary care? DTB 2009; 47: 138 - 141Generic prescribing in epilepsy DTB 2009; 47: 141 - 144
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:C. difficile outside hospital DTB 2009; 47: 133Managing gastro-oesophageal reflux in infants DTB 2009; 47: 134 - 137Strong opioids for osteoarthritis in primary care? DTB 2009; 47: 138 - 141Generic prescribing in epilepsy DTB 2009; 47: 141 - 144
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Uncommon knowledge DTB 2009; 47: 121Aspirin for primary prevention of cardiovascular disease? DTB 2009; 47: 122 - 125Over-the-counter weight loss with orlistat? DTB 2009; 47: 125 - 127Management of seasonal affective disorder DTB 2009; 47: 128 - 132
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Uncommon knowledge DTB 2009; 47: 121Aspirin for primary prevention of cardiovascular disease? DTB 2009; 47: 122 - 125Over-the-counter weight loss with orlistat? DTB 2009; 47: 125 - 127Management of seasonal affective disorder DTB 2009; 47: 128 - 132
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Generically speaking DTB 2009; 47: 109Does BNP testing aid diagnosis of heart failure? DTB 2009; 47: 110 - 113Imiquimod for superficial and in situ skin malignancy DTB 2009; 47: 113 - 116Anticoagulation with dabigatran or rivaroxaban DTB 2009; 47: 116 - 120
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Generically speaking DTB 2009; 47: 109Does BNP testing aid diagnosis of heart failure? DTB 2009; 47: 110 - 113Imiquimod for superficial and in situ skin malignancy DTB 2009; 47: 113 - 116Anticoagulation with dabigatran or rivaroxaban DTB 2009; 47: 116 - 120
The widespread use of oseltamivir (Tamiflu) has been a key strategy in tackling the H1N1 ‘swine flu’ pandemic in the UK. However, there have been growing concerns about the communication of this approach and rationale behind the policy itself. In this podcast Dr Ike Iheanacho, DTB editor, discusses the policy with two members of the DTB editorial board, Dr Paul Caldwell, a general practitioner and Dr Mahdad Noursadeghi, an infectious diseases consultant. This is an extension of our September 2009 Editorial, Tamiflu − the wrong message? DTB 2009; 47: 97.
The widespread use of oseltamivir (Tamiflu) has been a key strategy in tackling the H1N1 ‘swine flu’ pandemic in the UK. However, there have been growing concerns about the communication of this approach and rationale behind the policy itself. In this podcast Dr Ike Iheanacho, DTB editor, discusses the policy with two members of the DTB editorial board, Dr Paul Caldwell, a general practitioner and Dr Mahdad Noursadeghi, an infectious diseases consultant. This is an extension of our September 2009 Editorial, Tamiflu − the wrong message? DTB 2009; 47: 97.
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Tamiflu − the wrong message? DTB 2009; 47: 97Self-monitoring for patients on warfarin? DTB 2009; 47: 98 - 101Non-drug management of chronic low back pain DTB 2009; 47: 102 - 108Correction: How to misinform patients DTB 2009; 47: 108
